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Available online 30 August 2017Patients with an ‘At risk mental state’ (ARMS) for developing psychosis can be treated successfully with CBT to
postpone and prevent the transition to a first psychotic episode. A characteristic of individuals that meet ARMS
criteria is that they are still open for multiple explanations for extraordinary experiences. CBT aims to normalize
extraordinary experiences with education and to prevent delusional explanations. The treatment is not only ef-
fective, but also cost-saving in averting psychosis aswell as in reducing disability adjusted life years at 18- and 48-
month follow-up. Profiling within the ARMS group results in a personalized treatment. The screening and early
treatment for ARMS fulfills all the criteria of the World Health Organization and is ready to be routine screening
and treatment in mental health care.
At the same time, ARMS patients are complex patients withmulti-morbid disorders. Especially childhood trauma
is associated to ARMS status, together with co-morbid PTSD, depression, substance abuse and anxiety disorders.
Psychotic symptoms appear to be severity markers in other non-psychotic disorders. Preventing psychosis in
ARMS patients should be broadened to also address other disorders and aim to reduce chronicity of psychopa-
thology and improve social functioning in general.
Several mechanisms play a part in psychopathology in ARMS patients such as stress sensitivity as a result of ad-
verse experiences, dopamine sensitivity that is associated with salience and aggravates several cognitive biases,
dissociationmediating between trauma and hallucinations, and low self-esteem and self-stigma. New avenues to
treat the complexity of ARMS patients will be proposed.
© 2017 Elsevier B.V. All rights reserved.Keywords:
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Schizophrenia still has a poor prognosis despite the innovations in
pharmaceutical and psychosocial treatment. The duration of untreated
psychosis (DUP) was found to be associated with poor outcome and
suggested as a modifiable risk factor (McGlashan, 1999). A recent
meta-analysiswithmany studies found that a longDUPwas robustly as-
sociated with poor outcome (Penttilä et al., 2014). Birchwood and col-
leagues introduced the concept of the critical period of five years in
which patients with a short DUP needed optimal treatment to substan-
tially improve the outcome (Birchwood et al., 1998). This has led to the
implementation of numerous early intervention services. In these ser-
vices, some patients were detected with attenuated psychotic symp-
toms, who did not fulfill the criteria of a psychotic disorder (Yung and
McGorry, 1996). The profile was named ‘At Risk Mental State’ (ARMS)
(Yung et al., 2005). Ultra-high risk (UHR) is another name for the
same profile (Phillips et al., 2000). The ARMS population showed highag), d.vandenberg@parnassia.nlrates of transition into psychosis and this made the ARMS profile a
new target for indicated prevention of psychosis and the prevention of
accompanying intensive treatment trajectories (Yung et al., 2004).
1.1. Risk profile
The assessment instrument of ARMSwas developed by an Australian
group and set arbitrary, but reliable, criteria for 1) psychosis, 2) ARMS,
or 3) neither (Yung et al., 2005). The ARMS-profile comprises three
subgroups:
1) a group with attenuated psychotic symptoms;
2) a small familial risk group with a first degree relative with a psy-
chotic disorder; and.
3) a small group with a brief limited intermittent psychotic symptoms
(BLIPS) who had a florid psychosis that lasted less than seven days
and remitted spontaneously without treatment.
All subgroups are also characterized by social decline in recent
months (Yung et al., 2006). Individuals so identified merit clinical care
for current symptoms and impaired function. The transition risks at
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group, 24% in the attenuated symptoms group and 8% in the familial risk
group (Fusar-Poli et al., 2016a).
There are many routes to psychosis. This equifinality suggests that
various etiological mechanisms and developmental pathways have a
complex interplay. ARMS patients are found in all DSM classifications
in help-seeking patients and especially in mood and anxiety disorder,
substance abuse, and personality disorder (Rietdijk et al., 2012). Trauma
experience is very common in ARMS with 86.8% (Kraan et al., 2015b)
and associated with multi-morbidity in ARMS patients (Kraan et al.,
2015a, 2017; van Dam et al., 2015). Exposure to traumatic life experi-
ences can significantly impact the pathogenesis of psychotic experi-
ences as either a precipitating or exacerbating factor, and can lead to
psychosis outcomes through myriad pathways that intersect with ge-
netic or other environmental risk factors (Gibson et al., 2016). ARMS is
thus a heterogeneous risk profile and not a disorder.
1.2. Why treating a risk profile?
Treating heterogeneous risk profiles can be beneficial. The treatment
of blood pressure and cholesterol among other preventive interventions
has reduced coronary diseasewith 50% in the Netherlands (Koopman et
al., 2016). The progress in outcome of cancer treatment is also due to
early detection and early treatment, when prognosis is still good. Can
this staging model be applied to psychosis as well?
The difference between ARMS and FEP can be more than fluctuation
on a continuum. While ARMS patients seek help for depression or anx-
iety, they all fear that the perceptual aberrations signal imminent men-
tal breakdown. Psychotic patients do not in general seek help for their
psychosis as they consider the experiences not as symptoms, but as a re-
ality. That is a second difference, psychotic patients by definition have
lost part of the awareness and insight that something is wrong, while
ARMS patients are painfully aware that they are losing control over
their mental apparatus. They still have several explanations for their ex-
periences and convictions can change rapidly during the day, while psy-
chotic patients have delusional certainty and feel annoyed by different
views of others. This difference in uncertainty versus certainty also ex-
plains why ARMS patients are more receptive to psychoeducation and
eager for therapy, while psychotic patients are generally less interested
in psychoeducation as they consider themselves to be healthy and not
ill. The psychotic patient acts on his delusions, while the ARMS patient
often does not. Although psychotic experiences can largely be consid-
ered as continuous experiences, these differences in phenomenology
support the idea of meaningfully different stages. This also becomes ev-
ident in the differences in prognosis and the course of the symptoms.
The prognosis declineswith progression through the stages of psychosis
(see Table 1).
The risk for relapse or recurrence is a lifetime risk in psychotic disor-
der, while the risk of transition to psychosis is time limited in ARMS
with no more transitions after 10 or more years follow-up (Nelson et
al., 2013). Postponing transition for 10 years may mean lifetime
prevention.Table 1
Outcome characteristics of the different stages in psychosis.
Stage Remission Persistence
1a PLE 84% 8%
1b ARMS help-seeking 46% 27%
1b EDIE-NL control 57% 19%





3abc – 4 recurrent psychosis 14% 76%
PLE = psychotic-like experiences in the population; ARMS= help-seeking ultrahigh risk; FEP1.3. Why CBT for ARMS?
A number of studies were conducted to prevent the transition to
psychosis in patients with the ARMS profile. The interventionswere an-
tipsychotic medication, CBT, polyunsaturated fatty acids (PUFAs), or in-
tegrated therapy including psychoeducation, assertive community
treatment and social skills training (Nordentoft et al., 2006) or individ-
ual cognitive-behavioral therapy, group skills training, cognitive reme-
diation and multifamily psychoeducation (Bechdolf et al., 2012).
Meta-analyses showed that CBT was effective in reducing transition to
psychosis (Hutton and Taylor, 2014; van der Gaag et al., 2013b). Anti-
psychotic medication showed efficacy, but no more than CBT. Side-ef-
fects of medication resulted in low tolerance. PUFAs were promising,
but a recent large study showed no effect at all (McGorry et al., 2016).
Integrated psychosocial interventions appear promising, but need repli-
cation with more methodologically rigorous studies. Considering this
evidence base, the European guidelines based onmeta-analyses recom-
mend the detection of ARMS subjects with screening and structured di-
agnostic interviews and recommend CBT as a first line treatment to
prevent transition to psychosis (Schmidt et al., 2015; Schultze-Lutter
et al., 2015).
2. Cognitive model of ARMS and the methods and structure of the
CBT intervention
The neurocognitive model of psychosis has been refined in the last
decade, but still rests on aberrant salience, and biased appraisal pro-
cesses (Broyd et al., 2017; Kapur, 2003; van der Gaag, 2006).
The bottom-up biological process consists of increased striatal dopa-
mine release. This is associated to aberrant salience. Aberrant salience
opens the gates to consciousness for trivial stimuli to enter the center
of attention and the salient stimulus cries out for an appraisal. The sa-
lient subject feels that the stimulus has personal importance and that
acting upon it is needed (Kapur, 2003). Aberrant salience in ARMS pa-
tients can progress to psychotic symptoms (Howes et al., 2017).
The appraisal process that is elicited by aberrant salience is a key
mechanism of developing delusions. Emotional appraisal characterized
the group that evolved from developing a psychotic symptom to a clin-
ical condition in need of care (Hanssen et al., 2005). Those patients with
hallucinatory experiences at baselinewhodeveloped psychotic disorder
at 3-years follow-up, had developed delusional experiences at 1-year
follow-up. Other authors concluded that clinical outcome is related to
the development of secondary delusional beliefs (Daalman et al.,
2012; Krabbendam et al., 2004).
CBT should target appraisal processes that accompany perceptual
aberrations and suspiciousness to normalize the extraordinary experi-
ences and to prevent delusion formation and avoidance behaviors that
consolidate symptoms.
The appraisal processes in ARMS patients are biased by several cog-
nitive biases: jumping to conclusions, selective attention to threat and
an externalizing and personalizing bias. Jumping to conclusions (JTC)
is characteristic for delusional patients and for ARMS patientsPsychotic episode Reference
8% (Hanssen et al., 2005)
27% (Simon et al., 2013)
24% (van der Gaag et al., 2012)
12% (van der Gaag et al., 2012)
es Permanent psychosis
(Fusar-Poli et al., 2016a)
10% (Jääskeläinen et al., 2013)
(Wiersma et al., 1996)
= first episode psychosis; 1a–4 are stages in psychosis history.
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enhanced threat anticipation are associated with an increased intensity
of psychotic experiences in ARMS and psychosis (Reininghaus et al.,
2016). Psychotic patients with both persecutory and grandiose beliefs
showed an externalizing style for negative events,while thosewith per-
secutory beliefs in combinationwith depression showed a relatively ex-
ternalizing style for positive events (Jolley et al., 2006). ARMS
participants showed a greater tendency to perceive hostility and to
blame others in negative, ambiguous situations, and these attribution
style biases were linked to the level of paranoia and persecution beliefs
(An et al., 2010). Another study however did not confirm these findings
(Devylder et al., 2013).
CBT can address JTC by stressing the need for weighing alternative
explanations of situations by for instance using pie charts. Attention to
threat can be explored by exercises into selective attention in which pa-
tients learn that selective attention results in increased observations of a
certain stimulus and also increases anxiety. The externalizing and per-
sonalizing can for instance be tested with behavioral experiments.
Furthermore, patients are encouraged to discuss their extraordinary
experiences and their interpretations of the experiences with their
friends and relatives. The assumption is that reality always is a shared
reality. The therapist encourages to stay socially active, to keep going
to school and/or work, and to test negative appraisals in behavioral ex-
periments (van der Gaag et al., 2013a).
2.1. Frequent comorbidities
Most ARMS patients are also depressed, have low self-esteem and
have negative schemata about self, others and the world. Precipitating
factors are childhood trauma, bullying, social withdrawal and isolation.
CBT for ARMS may sometimes integrate the treatment of PTSD and
depression.
Cannabis use is discouraged. In general, this takes remarkable little
effort, becausemost ARMS patients have noticed that paranoid ideation
and other subclinical psychotic symptoms are amplified by cannabis use
and education that cannabis is a risk factor for a first episode of psycho-
sis helps to stop using cannabis in many patients.
3. Results of the different trials
Several RCTs have been conducted. The first one was the EDIE trial
byMorrison with 60 patients (Morrison et al., 2004). French andMorri-
son wrote a book with the protocol (French and Morrison, 2004). The
CBT intervention is based on a formulation-driven cognitive model
that prioritizes a collaboratively agreed problem list. It is problem-ori-
ented, time-limited and educational treatment, using collaborative em-
piricismwith guided discovery, behavioral experiments and homework
tasks. The model draws on strategies for change, including normaliza-
tion, generating and evaluating alternative beliefs, safety behaviors,
metacognitions, core beliefs, social isolation and relapse prevention.
Strategies used were selected in accordance with the formulation and
key problems identified on the participant's problem list.
Most other RCTs used the French and Morrison approach
(Addington et al., 2011; Morrison et al., 2012; Stain et al., 2016; van
der Gaag et al., 2012).
The Australian study inNewcastle enriched the French andMorrison
withMotivational Interviewing-CBT skills for thosewho presentedwith
hazardous substance misuse (Stain et al., 2016).
The Dutch EDIE-NL enriched the protocol with psychoeducation on
dopamine sensitization and the effects on perception and reasoning
and exercises to experience cognitive biases to be aware of them and
correct for the biases (van der Gaag et al., 2013a).
The Australian trial from Melbourne used their own four modules:
1) stress management, 2) depression/negative symptoms, 3) coping
strategies for positive symptoms, 4) other comorbidity such as anxiety
disorder, PTSD, substance use (McGorry et al., 2013; Yung et al.,2011). The latter treatment is an educational and not a personalized for-
mulation-driven approach.
An important difference between these trials is whether the social
functioning criterion was included in the prognostic model. Studies
that included attenuated symptoms without decreased social function-
ing had much lower transition rates.
Fourmeta-analyseswere published. The Stafford et al. meta-analysis
evaluated five RCTs at 6–12 month outcome and found a reduced num-
ber of transitions to psychosis and a Risk Ratio (RR) of 0.54 (Stafford et
al., 2013). The van der Gaag et al. meta-analysis used the same five RCTs
but had access to the 12 month outcomes of the Melbourne study and
found a RR of 0.52 (van der Gaag et al., 2013b). The total number of pa-
tients of the five studies was 708 subjects.
The Hutton et al. meta-analysis included the German study of CBT in
a comprehensive psychosocial package (Bechdolf et al., 2012) and also
found a RR of 0.52 (Hutton and Taylor, 2014). The Schmidt et al. meta-
analyses decided to take in ten studies (also medication and family in-
tervention) as they were homogeneous in their effects and found a
12-month RR of 0.44 (Schmidt et al., 2015).
The Newcastle study had 57 participants, but came out after the
meta-analyses and was negative in very young ARMS patients (Stain
et al., 2016). Including the study with the five CBT trials resulted in a
preserved RR of 0.54.
Another important result is on screening versus referral. The EDIE-
NL project screened all help-seeking patients in mental health services
in catchment area of The Hague (population 650,000), while the Am-
sterdam catchment area (population 750,000) included referred pa-
tients without screening. Screening the general help-seeking
population detected 93 ARMS patients, while referral detected 40 pa-
tients. Especially female ARMS patients are under detected in referrals.
Furthermore, the screened population had a higher transition rate
than the referred group (Rietdijk et al., 2012).
Although detection and postponement and prevention are feasible,
the effects on social functioning are disappointing. Preventing a psycho-
sis does not automatically result in more friends, jobs and quality of life.
Although social functioning improved at 18- and 48-months follow-up
in non-converters, the improvement was not statistically significant in
a meta-analysis (Schmidt et al., 2015). There must be more goals than
just the prevention of transition.
4. Conclusions and future developments
CBT for ARMS is successful in postponing and preventing the transi-
tion to psychosis. The treatment effect is still significant at 48-monts fol-
low-up and implementing screening, early detection and preventive
treatment is cost saving. The patients thatmake a transition to psychosis
do worse at follow-up and this explains the huge budget savings as
preventing psychosis pre-empts future mental health costs and also re-
duces productivity losses (Ising et al., 2017, 2015).
4.1. Clinical implications
An important clinical implication is that waiting for referral of ARMS
patients results in a low detection rate. Early intervention services
should try to implement screening in help-seeking populations.
Several screeners have been developed (Kline and Schiffman, 2014).
The PQ-16 is used to screen the help-seeking population in the Nether-
lands. The psychometric qualities of the PQ-16were replicated in a Chi-
nese university sample (Chen et al., 2016) as were the 29.1% of
converters over a two-year follow-up (Zhang et al., 2017). The screen-
ing at the entrance of routinemental health services results in 1.4% of al-
ready psychotic people and about 4% patients who fulfill ARMS criteria
(Ising et al., 2012).
Wilson and Jungner composed the ten WHO criteria that had to be
fulfilled before screening may be implemented in routine care (Wilson
and Jungner, 1968) and the screening and prevention of psychosis in
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an important health problem, because 36% will develop psychosis in
three years; 2) CBT is effective in reducing the transition rate; 3) a
screener, diagnostic interview and treatment protocol are at hand; 4)
ARMS is a latent stage of psychotic disorder; 5) the CAARMS and the
SIPS are the state of the art structured interviews to diagnose the
ARMS; 6) the PQ-16 is a 2-minute screen that can be applied to the gen-
eral (help-seeking) population; 7) transition to psychosis results in poor
prognosis and disablement; 8) there is evidence and consensus on the
definition of ARMS; 9) the prevention is cost-saving; and 10) screening
is already beginning to be implemented in routinemental health care in
the Netherlands.
Other clinical implications are the necessity to spread preventive
CBT for ARMS in mental health services. Referral will work, but routine
screening of help-seeking patients in mental health services has better
detection rates.
At several places in the world specialized services have been devel-
oped to screen, detect and treat patients with the ARMS profile. These
high-risk services are also beneficial for patients presenting with a
first episode of psychosis compared to routine mental health services.
In the London OASIS team patients spent fewer days in hospital, had a
shorter referral-to-diagnosis time, a lower frequency of hospital admis-
sion, and a lower likelihood of compulsory admission (Fusar-Poli et al.,
2016b).
4.2. Implications for mental health services and budgets
The therapy effects in the EDIE-NL trial could be accomplished and
save costs. Especially the direct medical costs were reduced and the in-
terventionwas cheaper than doing nothing at all. CBT for ARMS showed
an 83% probability of being more effective and less costly than Routine
Care (RC) (Ising et al., 2015). The 48-months follow-up results still
showed significant effects on transition rate and also the number of pa-
tients who fully remitted from subclinical psychotic symptoms was
higher in the CBT condition (Ising et al., 2016b). The societal cost-sav-
ings were even further improved with a 92% probability of being more
effective and less costly at 48-months (Ising et al., 2017).
Budget Impact Analyses takes an implementation time of 6 years
and then 40% of the targeted population will be included. Then the cu-
mulative savings are calculated over the next ten years. The net cash
value will be about € 26,000,000 Euro's cheaper than doing nothing in
the Netherlands. The prevalence of psychotic disorders can be reduced
with 15% in the long-term (Lokkerbol et al., 2016).
4.3. Further research: broadening the scope of the risk concept and the
treatment targets
A major problem is that patients who do not transition still func-
tion poorly in 43% (Brandizzi et al., 2015) and have 49% depression
and 35% anxiety disorder at follow-up (Lin et al., 2015). ARMS pa-
tients that have received both evidence-based treatment for their
dominant axis-1 disorder and CBT for ARMS do better with 13% de-
pression 20% anxiety disorder at 18-months follow-up (van der
Gaag et al., 2012).
The field shares the critique that a single focus on transition to psy-
chosis in ARMS is not enough (Addington and van der Gaag, 2015;
Fusar-Poli et al., 2015; Lin et al., 2015). Psychotic symptoms are a sever-
ity marker in for instance depression (Wigman et al., 2014). The screen-
ing approach in all help-seeking patients in mental health services is
already broadening the scope compared to projects with referred pa-
tients. The enrichment strategy with the combination of young age,
help-seeking for a psychiatric classification, decline in social functioning
and the ‘at risk’ criteria taken together selects manymore people at risk
for long-term treatment trajectories in mental health services (Rietdijk
et al., 2012). Adding broad spectrumadditional risk factors constituted a
predictor model consisting of five baseline variables (observed bluntedaffect, subjective complaints of impaired motor function, subjectively
experienced social marginalization, decline in social functioning, and
distress associated with suspiciousness) may significantly improve ac-
curacy in predicting future psychosis and persistent low functioning in
a help-seeking ARMS sample of patients (Ising et al., 2016a). The profil-
ing within the risk groups opens up personalized treatment for this
group varying from short psychoeducation tot multi-specialist treat-
ment and outreach to spouses, families, schools and workplaces to pre-
serve social functioning.
Childhood trauma predicted poor employment outcome in ARMS
patients (Cotter et al., 2017) and physical abuse and emotional ne-
glect was negatively associated with social functioning, while child-
hood trauma was not associated with transition to psychosis at the
4-year follow-up in the EDIE-NL trial (Kraan et al., 2017). An effect
of trauma on social functioning and not on the transition to psychosis
was also found in the DUPS cohort (Kraan et al., 2015a). So, the late
effects of childhood trauma contribute to persistent low social func-
tioning, independent from attenuated psychotic symptoms. ARMS
patients have been traumatized in 87% of the cases (Kraan et al.,
2015b) and treating PTSD in psychotic patients is feasible, safe and
effective (van den Berg et al., 2015, 2016). To improve the outcome
of ARMS patients, the prevention of transition to psychosis and the
treatment of PTSD are both contributing to health and social well-
being and are indicated treatments.
Other psychosocial components that were suggested are social skills
training and family involvement to create a supportive environment
(Thompson et al., 2015).
We disagreewith some critics that state that the high-risk strategy is
inefficient and a public health approach is better (van Os and Guloksuz,
2017). The evidence at this moment favors the high-risk approach as in
oncology and coronary diseases, while evidence for public health ap-
proaches is lacking and unlikely to accomplish. The necessary develop-
ment in near future will be to combine transition psychiatry with low
threshold services for young people with specialized detection of high
risk patients with low incidence. Headspace, founded on the staging
concept of psychotic disorders, is a good example of such a low stigma-
tizing access of young people to mental health services and at the same
time screening for developing severe mental illness characterized by
emerging psychotic symptoms.
4.4. Concluding comments
Much was accomplished in a relatively short time. Screening and
treatment of subjects at high risk for developing psychosis and
other major multimorbid psychiatric disorders is feasible. CBT is
effective in postponing and preventing a first episode psychosis in
a 4-year period. The scope of the intervention must be broadened
to treatment of the multimorbid disorders in order to prevent chro-
nicity and above all foster good social functioning. Evidence-based
treatment of established disorders is important, but indicated pre-
vention in ARMS patients can actually reduce incidence rates.
There are cost savings in direct medical costs, because of reduced
health care consumption, and there are also savings in society, be-
cause less people have financial benefits and more have a paid job
and pay taxes. CBT for ARMS has been included in the European
guidelines and awaits dissemination and implementation in mental
health services.
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